Delivery Order SPE2DB20D1100-SPE2DB24FC2A1

Award Date 6/10/24
Potential Completion Date 6/11/24
Potential Value $43K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,305.60 firm-fixed-price delivery order is for the supply of 4 mg Ondansetron orally disintegrating tablets in 30-count bottles. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,643.99 firm fixed-price delivery order contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract has an ultimate completion date of May 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,452.62 firm fixed price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,703.54 firm fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in quantities of 30. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen to provide a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,919.77 firm fixed-price delivery order contract is for the supply of 4 mg ondansetron orally disintegrating tablets. The contract has an ultimate completion date of December 14, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,832.02 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCl tablets. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,032.52 firm fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in quantities of 30 per bottle. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,385.89 firm fixed price delivery order is for the supply of 4 mg Ondansetron HCL tablets. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,611.51 Firm Fixed Price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract has an ultimate completion date of October 23, 2023 and was awarded on October 20, 2022. There is no set-aside designation on this contract. AmerisourceBergen also holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,217.92 firm fixed-price delivery order is for the supply of 4 mg Ondansetron ODT (Orally Disintegrating Tablet) in 30-count packages. This award is not associated with a larger contracting vehicle and does not have a set-aside designation, indicating open competition. AmerisourceBergen has an Indefinite...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC2A1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,851.26 firm fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in quantities of 30 per bottle. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive experience in federal healthcare contracting and its ability to efficiently distribute a wide array of critical medical commodities make it a valuable partner for the DLA in meeting the pharmaceutical and medical supply needs of the U.S. military and other federal beneficiaries.

Generated 5/16/25, 11:45 AM